Enriched melatonin (MEL) has been found in the mammalian intestine and has been recently demonstrated to alleviate rodent colitis. In this study, the effect of MEL on lipopolysaccharide (LPS)-induced intestinal inflammations was investigated in new chicken hatchlings. The chicks were fed with a diet supplemented with MEL (12.5 mg/day) from D1 to D10. Meanwhile, the chicks in the LPS or MEL + LPS groups were injected with LPS (10 mg/kg BW, i.p.) at D10. LPS treatment for 6 h increased the expression of IL-6, IL-4, caspase-3 mRNAs and TUNEL-positive cell populations, but decreased populations of the goblet and PCNA + cells, IgA production and the expression of MUC2 mRNA in the duodenum. Compared with the LPS group, MEL pre-feeding alleviated duodenal inflammation and decreased the expression of TNF-α mRNAs by 23.6% (P = 0.004), IL-6 mRNAs by 69.4% (P = 0.001), IL-4 mRNAs by 4.1% (P = 0.824) and caspase-3 mRNAs by 45.8% (P < 0.001). Conversely, MEL pre-feeding attenuated the LPS-induced changes of IgA production by 161.6% (P = 0.013) and PCNA + cell populations by 172.1% (P < 0.001) in the duodenum. TLR4 mRNA was also upregulated by LPS treatment but down-regulated by MEL pre-feeding. In conclusion, dietary MEL could attenuate LPS-induced chick duodenal inflammation by down-regulating the expression of inflammatory cytokines, promoting epithelial cell proliferation, improving the immunological barrier and inhibiting epithelial apoptosis via the mediation of TLR4.
INTRODUCTION
Inflammation is a complex response of an organism to harmful stimuli. It is accompanied by changes in the secretion levels of a diverse number of cytokines and by changes in classification of cell populations. It has been demonstrated that human inflammatory bowel disease and mouse colitis are both accompanied by a decrease in goblet cells populations and MUC2 expression (Hoebler et al., 2006; Kim and Ho, 2010) . In the macrophages, lipopolysaccharides (LPS) can induce the increased production of TNF-α, IL-1β, IL-6, and IL-8 (Xia et al., 2012) . Dextran sodium sulfate (DSS)-induced mouse colitis manifested with increased apoptosis and decreased proliferation in the intestinal mucosal epithelium (Araki et al., 2010) . During the process of inflammation, Toll-like receptors (TLRs) serve as key mediators in inflammatory responses where the stimulation of LPS can be transferred into intestinal epithelium by the TLRs (Cario et al., 2000; Erridge, 2010) . However, the inflammation process could also be regulated by many other factors.
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Melatonin (MEL) is produced mainly by the pineal gland and plays a crucial role in many physiological functions, such as benefiting inflammatory bowel disease in rats (Mazzon et al., 2006) and improving chickens' intestinal mucosal renewal (Li et al., 2017) and rats' duodenal barrier functions (Sommansson et al., 2014) . In vertebrates, the MEL level in the intestine is almost 10 to 100 times higher than that in the plasma (Bubenik and Brown, 1997; Bubenik, 2008) . In the rat, significantly higher MEL levels were found in the jejunum and ileum than in other intestine segments (Bubenik and Brown, 1997) . These indicate that MEL plays a pivotal physiological function in the intestines. Interestingly, MEL has been observed to attenuate DSS-induced mouse ulcerative colitis (Chung et al., 2014) and acetic acid-induced rat colitis (Sayyed et al., 2013) . MEL treatment was able to rescue the LPS-induced proinflammatory cytokine up-regulation in the macrophages (Xia et al., 2012) . MEL could also alter the distribution of the goblet cells within mouse crypts (Pentney and Bubenik, 1995) , increase plasma IgA levels in humans (Maldonado et al. 2012 ) and promote proliferation and migration rates in the chicken small intestine mucosal epithelium (Li et al., 2017) . Conversely, in the rat, MEL was seen to reduce radiotherapy-induced intestinal mucosal apoptosis (Fernández-Gil et al., 2017) . Furthermore, MEL could regulate TLR4-mediated 2295 inflammation through MyD88-and TRIF-dependent signaling (Xia et al., 2012) . Whether MEL exerts any such anti-inflammation functions in the poultry intestine is still unclear.
In the present study, we investigate the regulation of MEL on LPS-induced changes in goblet cell function, IgA secretion, epithelium proliferation and epithelium apoptosis in the chicken intestinal mucosa. Moreover, the role of TLR4 during LPS induced chicken intestinal inflammation is also analyzed.
MATERIAL AND METHOD

Animals
Fertilized HyLine chicken (Gallus gallus) eggs were obtained from a commercial hatchery and incubated in an incubator (38.5
• C, 60% humidity) until hatch. Posthatch, the chicks were divided into 4 groups: control, MEL, LPS and MEL + LPS groups (n = 25). From D1 to D10, chicks in MEL and MEL + LPS groups were fed with diet containing MEL (Sigma, St. Louis, MO) at the dosage of 12.5 mg/day by referring to our preliminary experiment and references of Jia et al. (2016) and Taylor et al. (2013) . At D10, LPS at 10 mg/kg BW was injected intraperitoneally into the chicks in the LPS and MEL + LPS groups. At the same time, the chicks in MEL group were injected with 0.9% saline. After 6 h of injection, the duodenum was removed and fixed in 4% paraformaldehyde or kept in liquid nitrogen. The chicks were reared under photostimulatory conditions (16 h light/8 h dark) and had ad libitum access to feed and water. The diet was formulated to meet or exceed the nutritional requirements of the poultry (NRC, 1994 
Histological Observation
The collected duodenum was divided into 3 parts (forepart, middle, and posteriors) and respectively prepared for paraffin section (5 μm thickness, 10 slides/part). Hematoxylin & eosin (HE) staining and Alcian blue-periodic acid Schiff (AB-PAS) reactions were performed to observe neutrophil infiltration and goblet cells.
For immunostaining, the duodenum sections were incubated with mouse antibody against proliferating cell nuclear antigen (PCNA, Abcam, ab29, Cambridge, UK) or goat anti-chicken antibody against IgA (Bethyl, A30-103A, Montgomery, TX) overnight at 4
• C. Biotin anti-mouse or anti-goat IgG was used as the secondary antibody and 3,3 -diaminobenzidine (DAB) as the chromogen.
Western Blot Analysis
Protein was extracted from 0.1 g duodenum using 1 mL RIPA lysing buffer (Beyotime, Nantong, China) containing 10 μL 100 mM PMSF (ST506, Beyotime, Nantong, China). The protein was then separated on 12% SDS-PAGE, followed by electrotransfer to a polyvinylidene fluoride membrane (PVDF, Millipore, Billerica, MA). The membrane was incubated with mouse antibody against PCNA (Abcam, ab29, Cambridge, UK), goat anti-chicken IgA antibody (Bethyl, A30-103A, Montgomery, TX) or mouse antiavian β-actin antibody (sc-47778, Santa Cruz, Dallas, TX) at 4
• C overnight. After incubating with horseradish peroxidase-labeled secondary antibody for 1 h at 37
• C, the membranes were visualized using an ECL system (BioRad Laboratories, Inc., Hercules, CA). The data was expressed as the integral optical density (IOD) of the bands that were normalized to the IOD of the corresponding β-actin band. Results were obtained from 3 replicates.
TUNEL Assay
A terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling (TUNEL) kit (Vazyme Biotech Co, Ltd, Nanjing, China) was used to detect DNA-damage-based apoptosis on the mucosal epithelium. Briefly, duodenum sections were incubated in 20 μg/mL proteinase K for 20 min at room temperature. They were then incubated in 1 × equilibration buffer for 20 min and labeled with a 1 × TdT labeling mixture for 1 h at 37
• C. Finally, the nuclei were counterstained with DAPI (300 nM, Sigma, St. Louis, MO). The apoptotic cells were shown in green.
RNA Extraction and Quantitative Real-Time Polymerase Chain Reaction
Total RNA was extracted from the chick duodenum using Trizol reagent (Invitrogen Co., Carlsbad, CA). Expression of the mRNAs of MUC2, inflammatory cytokines and apoptosis genes were determined using a quantitative real time polymerase chain reaction (qRT-PCR) with primers listed in Table 1 . The qRT-PCR was carried out on an ABI 7500 HT RealTime PCR machine (Applied Biosystems, Foster City, CA) with the reaction volume of 20 μL consisting of a 2 μL complementary DNA template, 400 nM of each of the gene-specific forward and reverse primers, 0.4 μL ROX reference dye II, and 10 μL SYBR Premix Ex Taq (TaKaRa BioInc, Shiga, Japan). The thermal profile was 95
• C for 10 s and 95
• C for 5 s for 40 cycles, followed by 60
• C for 34 s each. Individual samples were analyzed in triplicate and all experiments were performed 3 times. All samples were normalized with β-actin using the comparative cycle threshold method (2 − Ct ).
Statistical Analysis
Data was expressed as means ± SEM and analyzed by one-way analysis of variance (ANOVA) using SPSS 20.0 (SPSS Inc., Chicago, IL). Statistical differences among different groups were evaluated by a least significant difference post hoc multiple comparisons test. The significance level was set at P < 0.05.
RESULTS
Effect of MEL on LPS-Induced Duodenum Inflammation
HE staining was performed to verify the effect of MEL on LPS-induced intestinal mucosal structural change in the duodenum. As shown in Figure 1 , few neutrophil infiltrations (black arrows) and almost no mucosal injuries were observed in either control or MEL groups. After LPS treatment, an increased amount of neutrophils could be observed at the sub-mucosa area ( Figure 1C) . However, the MEL + LPS group showed notably reduced neutrophil infiltration compared with the LPS group ( Figure 1D) .
The results from qRT-PCR analysis showed that MEL pre-feeding could significantly decrease the inflammatory cytokine expression in the duodenum that was up-regulated by LPS treatment (Figure 2) . Compared with the control group, LPS treatment significantly increased the expression of IL-6 and IL-4 mRNAs by 215.3% (P = 0.001) and 65.4% (P = 0.043) respectively. However, combined treatment of MEL decreased the up-regulated expression of TNF-α, IL-6, and IL-4 mRNAs by 23.6% (P = 0.004), 69.4% (P = 0.001) and 4.1% (P = 0.824), respectively.
Effect of MEL on LPS-Induced Intestinal Mucosal Immunologic Barrier Damage
Goblet cells were observed at the villus and upper crypts ( Figure 3A and 3B). MEL pre-feeding could rescue the decreased density of the goblet cells induced by LPS treatment. Statistical results of qRT-PCR ( Figure 3D ) showed that treatment of MEL alone led to an increased expression of MUC2 mRNA by 45.93% (P = 0.008). LPS treatment also resulted in a slightly decreased expression of MUC2 mRNA (by 1.0%, P = 0.942). However, compared with the LPS group, combined treatment of MEL increased MUC2 mRNA abundance by 33.5% (P = 0.014).
As an important component in the mucosal immunity, IgA + cells appeared at the lamina propria (brown color within white line, Figure 3C ). Western blot analysis ( Figure 3E and 3F) revealed that administration of LPS could slightly decrease IgA expression by 33.2% (P = 0.400) as compared with control group. MEL treatment could significantly attenuate LPS-induced decrease of IgA production at the duodenum. Compared with the LPS group, IgA production in the MEL + LPS group was significantly up-regulated by 161.6% (P = 0.013).
Effects of MEL on LPS-Induced Mucosal Epithelial Cell Proliferation and Apoptosis
A large amount of PCNA + cells were observed at the intestinal crypts (brown nuclei, Figure 4A ). Analysis of PCNA protein by Western blot ( Figure 4C and 4E) showed that MEL treatment could rescue the LPSinduced decrease in PCNA + cell number. Compared with the control group, LPS treatment reduced PCNA protein expression by 20.3% (P = 0.299). However, cotreatment of MEL and LPS elevated PCNA expression by 172.1% (P < 0.001), as compared with LPS group.
In Figure 4B , epithelial cells with DNA fragmentation are shown in green. LPS treatment could notably increase DNA fragmentation in the duodenum but this was reduced by MEL pre-feeding. The detection of caspase-3 mRNA ( Figure 4D ) showed that LPS treatment remarkably increased caspase-3 mRNA by 57.8% (P < 0.001) as compared with the control group. However, pretreatment with MEL could significantly down-regulate the LPS induced expression of caspase-3 mRNA by 45.8% (P < 0.001).
Effect of MEL and LPS on Expression of TLR-4 mRNA
To further investigate how MEL regulates LPS-induced inflammation in the duodenum, the expression of TLR-4 (LPS receptor) mRNA was detected by qRT-PCR. As shown in Figure 5 , LPS treatment significantly increased TLR-4 mRNA expression by 42.1% (P = 0.002) as compared with control group, but this was attenuated by a simultaneous treatment of MEL. Compared to the LPS treatment group, TLR-4 mRNA expression in MEL and the LPS co-treatment group had decreased by 68.0% (P < 0.001).
DISCUSSION
Intestinal inflammation is a serious and common disease in broiler chickens that can decrease production or even cause sudden death. The present study showed that LPS acts to induce inflammatory cell infiltration in the sub-mucosa of the chick duodenum and to increase IL-6 and IL-4 mRNA expression. However, MEL pre-feeding was able to significantly alleviate this inflammatory response in the chicken duodenal mucosa. Similarly, MEL treatment was demonstrated to reduce TNF-α, IL-1β, IL-6, and IL-8 in LPS-stimulated macrophages (Xia et al., 2012) . Previous studies had demonstrated that MEL treatment could attenuate both DSS induced ulcerative colitis in mice, by regulating the expression of adiponectin, aquaporin 8, E2F2 and H2-Ab1 (Chung et al., 2014) and attenuate acetic acid-induced colitis in the rat, by reducing nuclear factor-kappa beta (Sayyed et al., 2013) . Our results indicate that MEL can attenuate LPS-induced inflammation in the chicken duodenum in a manner that resembles those reports of similar effects in the mammalian intestine.
The mucosal immunological barrier, comprising mainly of goblet cells and IgA + plasma cells, is an important component which constitutes an innate defense barrier against intestinal pathogens. MUC2, secreted by the goblet cells, forms an organized mucus layer that constitutes the first physical barrier of the intestine. It has been demonstrated that LPS could reduce the expression of MUC2 mRNA in broiler chickens (Gadde et al., 2017) . In the present study, LPS treatment markedly reduced goblet cell and IgA + cell populations, MUC2 mRNA expression and IgA protein levels in the duodenum. However, MEL pre-feeding could rescue this LPS-induced decrease in terms of goblet cell density, MUC2 mRNA abundance and IgA levels in the chicken duodenum. MEL treatment was able to consistently increase the amount of goblet cells in mouse intestinal villus (Pentney and Bubenik, 1995) and increase plasma IgA levels (Maldonado et al., 2012) . These studies indicated that exogenous MEL treatment can improve the function of the intestinal immunological barrier.
The physical mucosal barrier is another important component that represents the dominant nutrition absorption site and prevents the translocation of luminal macro-molecular contents into the inner tissues. This physical barrier is mainly comprised of the epithelial cells of which homeostasis is a key factor influencing the physical barrier's function. The balance between cell proliferation and apoptosis acts to maintain the homeostasis of the intestinal mucosa. In our study, PCNA expression in the crypts of the chicken duodenum was repressed by LPS administration, but this reduction was attenuated by MEL pre-feeding. Supportively, MEL could alleviate dexamethasone-induced inhibitory effect on rat hippocampus progenitor cell proliferation (Ekthuwapranee et al., 2015) . On the other hand, the present study showed that both the percentage of TUNEL-positive cells and caspase-3 expression were increased by LPS treatment. This negative effect of LPS was also counteracted by MEL pre-feeding. Consistently, MEL could protect the liver against LPS-induced injury by suppressing cell apoptosis (Wang et al., 2007) . These studies indicated that MEL can rescue LPS-induced decrease in cell proliferation and increase in cell apoptosis in the duodenal mucosa.
TLR4 plays a pivotal role as a LPS receptor and can transfer the LPS signal into the intestinal mucosal epithelium (Cario et al., 2000) . LPS injections have been previously demonstrated to lead to an increase in the expression of TLR4 mRNA in the enterocytes in vitro (Jiang et al., 2015) . The present study showed that LPS induced-increase in TLR4 mRNA expression was accompanied with duodenal inflammation. However, MEL pre-feeding reduced the LPS-induced elevation in TLR4 mRNA abundance. Similarly, MEL treatment was able to suppress the expression of TLR4 mRNA in LPS-induced mice mastitis (Shao et al., 2015) . Wang et al (2013) showed that MEL treatment (150 mg/kg, i.p.) could markedly decrease the expressions of TLR4 mRNA in rat subarachnoid hemorrhage. The above results imply that MEL can similarly suppress TLR4 signaling transduction and further attenuate the process of inflammation in the chicken duodenum.
In summary, in the chick duodenum, LPS treatment resulted in damage of the balance between proliferation and apoptosis of the epithelial cells, weakened the immunological barrier, and finally induced mucosal inflammation. However, MEL pre-feeding was able to effectively alleviate LPS-induced inflammation by restoring epithelial homeostasis and strengthening the immunological barrier. Moreover, TLR4 signaling mediated the attenuating effect of MEL on LPS-induced duodenal inflammation.
